Table 1.
Polyphenol | Type of Skin Cells | Assay Conditions | Effect | Reference |
---|---|---|---|---|
Hydroxytyrosol and Oleuropein | neonatal human dermal fibroblasts | 1 μM hydroxytyrosol or 10 μM oleuropein | reduced SA-β-Gal-positive cell number and p16INK4A protein expression |
[299] |
Apigenin | human foreskin fibroblasts | 10 or 20 μM for 24 h co-treated with bleomycin | decreased expression of IL-6, IL-8 and IL-1β mRNA; inhibited NF-κB activity |
[300] |
NHDF | 15 mM 1 h before and after UVB-exposure | downregulated NER expression; inhibited nuclear fragmentation and Bax and caspase-3 expression |
[175] | |
Kaempferol | human foreskin fibroblasts | 10 or 20 μM for 24 h co-treated with bleomycin | decreased expression of IL-6, IL-8 and IL-1β mRNA | [300] |
Quercetin | human foreskin fibroblasts | 10 or 20 μM for 24 h co-treated with bleomycin | decreased expression of IL-6, IL-8 and IL-1β mRNA; reduced SA-β-Gal |
[300] |
Naringenin | human foreskin fibroblasts | 10 or 20 μM for 24 h co-treated with bleomycin | reduced SA-β-Gal | [300] |
Bergamot polyphenol fraction | HaCaT | UVB-exposed | modulation of IL-1β; restored telomere length and telomerase activity |
[302] |
Genistein | NHDF and keratinocytes co-culture | 10 mM for 72 h after UVB exposure | inhibited IL-6 production; inhibited phosphorylation of p38, ERK and JNK |
[303] |
Rooibos methanolic and aqueous extracts | HaCaT | sub-lethal concentrations (0.05–0.55 mg/mL) for 24 h after UVB exposure | inhibited viability and proliferation facilitating the removal of accumulating icIL-1a |
[304] |
Honeybush aqueous extracts | HaCaT | 0.10–0.79 mg/mL for 24 h after UVB exposure | inhibited icIL-1a accumulation; increased caspase-3 activity in damaged cells (with opposing effect found for methanolic extract) |
[304] |
Pomegranate fruit extract | NHEK | 10–40 mg/mL for 24 h before UVB exposure | inhibited phosphorylation of ERK1 and 2, JNK1 and 2 and p38; inhibited phosphorylation of IκBα and IKKα; inhibited translocation of NF-κB/p65 |
[307] |
SKU-1064 skin fibroblasts | 5–60 mg/L for 2 h after UVB exposure | reduced activation of NF-κB; downregulation of caspase-3; increased G0/G1 phase arrest associated with DNA repair |
[310] | |
Phloretin | HaCaT | 50–200 mg/mL 12 h after UVB exposure | decreased DNA damage; reduced phosphorylation of p53 and γ-H2AX; inhibited IL-6 and prostaglandin E2 |
[308] |
Salidroside | NHDF | 1–10 mM for 24 h before UVB exposure | recovered viability; decreased SA-β-Gal-positive cells; relieved G1/G0 cell cycle arrest; suppressed p21CIP/Waf1 and p16INK4A expression; reduced MMP-1 activity; reduced IL-6 and TNF-α production |
[305] |
Grape seed proanthocyanidins | NHEK | 10–50 mM for 3–6 h before UVB exposure | inhibited intracellular release of H2O2; inhibited photo-oxidative damage of lipids and proteins; inhibited oxidative DNA damage; inhibited phosphorylation of ERK1 and 2, JNK and p38 |
[309] |
Glycyrrhizic acid | Hs68 foreskin fibroblasts | 10–25 mM for 16 h before UVB exposure | reduced ROS levels; restored Ca2+ levels; inhibited ER stress; reduced phosphorylation of p38 and JNK |
[313] |
Gallic acid | NDHF, HaCaT | 0.1–10 mM for 24 h after UVB exposure | decreased IL-6; decreased MMP-1 levels; decreased ROS production; suppressed phosphorylation of AP-1 |
[314] |
Piceatannol | NHEK | 0–2 mg/mL for 24 h before UVB exposure | suppressed ROS generation; reduced MMP-1 induction |
[315] |
Fisetin | HaCaT | 1–20 mM for 12 h cotreated with H2O2 (500 mM) or pre-treatment for 6 h before TNF-α stimulation | reduced ROS production; inhibited IL-1β and IL-6 production; decreased iNOS and COX-2 expression; increased Nrf2-mediated HO-1 expression |
[316] |
Brown pine leaf extract (BPLE) andtrans-communic acid (TCA) | HaCaT, reconstructed human skin models |
BPLE (5, 10 μg/mL) and TCA (5, 10 μM) for 1 h before UVB exposure |
inhibited MMP-1 expression; suppressed AP-1 expression; inhibited Akt and PI3K phosphorylation |
[317] |
Orange peel extract | HaCaT | 0.1–10 mg/mL prior to UVB exposure | suppressed COX-2 and PGE2 expression; activation of PPAR-γ |
[319] |
Wogonin | NIH/3T3 mouse skin fibroblasts | TPA, IL-1β and TNF-α and 10–100 mM wogonin for up to 2 h | decreased COX-2 and iNOS expression | [345] |
HaCaT | 0.1–10 mM for 72 h after UVB exposure | inhibited MMP-1 and IL-6; blocked MAPK/AP-1 and NF-κB pathways |
[346] | |
Baicalin | human skin samples | 6.25–25 mg/mL after UVB exposure | decreased number of SA-β-Gal-positive cells; reduced G0/G1-phase cells; decreased expression of p16INK4A, p21CIP/Waf1 and p53; decrease in γ-H2AX levels; decreased expression of MMP-1 and MMP-3 |
[320] |
Delphinidin | HaCaT | 5 or 10 µM before or after UVB exposure | restored elastic properties | [321] |
Extracts from yerba mate | HaCaT, BJ fibroblasts | 100–1000 µg/mL extracts | enhanced viability; inhibited activity of lipoxygenase, collagenase and elastase enzymes | [322] |
Extracts from leaves of Cleistocalyx nervosum var. paniala | human skin fibroblasts mushroom tyrosinase |
0.1 mg/ml | inhibition of MMP-2, ROS scavenging, lipid peroxidation inhibition, tyrosinase inhibition effect | [324] |
Mangiferin | human dermal fibroblasts | 10 μM/50 μM; 2 h followed by addition of H2O2 (10 μM) | decreased ROS production, stabilized mitochondrial membrane potential and decreased the number of cell cycle arrested cells | [323] |
Extracts from three species of seaweeds Alariaceae, Eisenia bicyclis, Ecklonia cava and Ecklonia stolonifera; eckol, dieckol, eckstolonol, triphlorethol-A and phloroglucinol | human dermal fibroblasts; HeLa cells transfected with the NF-κB or AP-1 luciferase reporter plasmid DNA; mushroom tyrosinase; B16F10 mouse melanoma cells; Zebrafish embryos; male 7-week-old Balb/c mice |
10 μg/mL extracts before treatment with TNF-α (10 ng/mL); exposure to UVB (50 mJ/cm2) + phlorotannins (0.5–250 μM); zebrafish embryos preincubated with 50 μM phlorotannins for 1 h; phloroglucinol (10 or 50 mg/mL) applied to dorsal skin plus UVB (30 or 60 mJ/cm2) |
inhibited MMP-1; blocked AP-1 and NF-κB reporter activities; inhibition of tyrosinase, melanogenesis and DNA damage; reduction in ROS, NO, biomarkers of oxidative damage, cell death and hyperpigmentation in vivo; reduction in number of mast cells and increase in the epidermal and dermal thickness |
[328,329,330] |
Phloroglucinnol | human WI-38 fibroblasts | 10, 25, 50, or 100 μg/mL phloroglucinol for 24 h after tratment with 50 μM H2O2 for 60 min | decrease in MDA in prematurely senescent cells and viability increase | [331] |
Polyphenol-rich extract from the seaweed Sargassum vachellianum | free radical scavenging, anti-tyrosinase activity and moisture absorption and retention assay | 200–1000 μg/mL | potential in scavenging OH radical, and effective absorption of the UVB and UVA rays | [333] |
Polyphenol-rich root extracts from Potentilla atrosanguinea | determination of total phenol content; free radical scavenging activity | dried aqueous-methanolic (H2O/MeOH) crude extract and ethyl acetate (EtOAc), n-butanol (n-BuOH), as well as aqueous (H2O) fractions of roots were evaluated (200 μg/mL) | H2O/MeOH crude extract showed highest antioxidant of DPPH radical scavenging, O2.− scavenging and Cu2+ reducing activity; photoprotective agents in sunscreen preparation; effective natural antioxidant |
[325] |
Extract from tomato stem cell (Lycopersicon esculentum) | murin fibroblasts NIH-3T3; HaCaT | different concentration of the extract for 12 h or 2 h and/or CuSO4 for 30 min | reduced heavy metal-induced toxicity, restored DNA integrity under heavy metal stress; decreased collagen degradation and renewed collagen synthesis | [326] |
Verbascoside | HaCaT | 100 or 200 μmol/L added 2 min before UVC irradiation (20 min, 1.8 J/cm2) | decreased AP-1 and NF-κB and decreased level of proinflammatory mediators | [327] |
Extract from the parasitic mushroom Inonotus obliquus | skin fibroblasts, keratinocytes or reconstructed epidermis | 2% aqueous extract added 2 h before UV irradiation (UV-A (5 J/cm2) + UV-B (100 mJ/cm2) | reduced ROS formation, reduced quantity of pro-inflammatory cytokines and increased DNA repair activity | [334] |
Extract of the mycelium of Tricholoma matsuke | human skin fibroblasts | 0.1–100 μg/mL for 72 h and 24 h treatment in μcombination with TPA | decreased elastase activity, reduced the MMPs level | [336] |
Quercetin surface functionalized Fe3O4 nanoparticles | senescent human foreskin fibroblasts BJ; senescence induced by 100 μM H2O2 for 2 h | treatment with 5 μg/mL for 24 h | decreased number of stress-induced senescent cells; promoted AMPK activity; reduced IL-8 and IFN-β | [340] |
Quercetin/dasatinib | senescent MEFs from Ercc1−/− mice | 48 h treatment dasatinib (250 nM), quercetin (50 μM) |
Reduction in senescent and total cell counts | [144,146] |
Fisetin | senescent MEFs from Ercc1−/− mice, IMR-90 fibroblasts |
48 h treatment, 1–15 μM |
Reduction in the fraction of SA-ß-Gal-positive cells | [341] |
Curcumin luteolin |
senescent MEFs from Ercc1−/− mice | 48 h treatment, 5 μM |
Reduction in the fraction of SA-ß-Gal-positive cells | [341] |
Curcumin analog EF24 | senescent WI-38 and IMR-90 fibroblasts; senescence induced by replication, oncogene and IR | 72 h treatment | Selective killing of senescent cells; EC50 = 0.33–1.74 μM; proteasomal degradation of the Bcl-2 anti-apoptotic protein family proteins; independent of ROS | [342] |
Rhododendron ferrugineum leaves extract | senescent NHDF; senescence induced by 500 µM H2O2 for 2 h |
48 h treatment, 1% extract |
Reduction in SA-ß-Gal-positive cells | [344] |
AP-1, activator protein 1; COX-2, cyclooxygenase 2; DPPH, 2,2-diphenyl-1-picryl-hydrazyl-hydrate; ER, endoplasmic reticulum; ERK, extracellular-signal-regulated kinase; HaCaT, human immortalized keratinocytes; HO-1, heme-oxygenase 1; IFN-β, interferon beta; IL-1, -6, -8, interleukin 1, 6, 8; iNOS, inducible nitric oxide synthetase; IR, ionization radiation; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MDA, malondialdehyde; MEFs, mouse embryonic fibroblasts; MMP-1, matrix metalloproteinase 1; NHDF, normal human dermal fibroblasts; NHEK, normal human epidermal keratinocytes; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; NO, nitric oxide; Nrf2, nuclear factor erythroid 2–related factor 2; PGE2, prostaglandin 2 PI3K, phosphatidylinositol 3-kinase; PPAR-γ, peroxisome proliferator-activated receptor gamma; ROS, reactive oxygen species; SA-β-Gal, senescence associated b-galactosidase.